FMCT Funds Research into Hexokinase 2 Inhibitors at Johns Hopkins

FMCT Funds Research into Hexokinase 2 Inhibitors at Johns Hopkins

The Foundation for Metabolic Cancer Therapies has awarded a research grant to Dr. Peter Pedersen at John Hopkins School of Medicine. The research will focus on screening for Hexokinase 2 inhibitors. Hexokinase 2 represents one of the most promising metabolic targets within the cancer cell. Dr. Pedersen is an outstanding biochemical researcher with an extraordinary track record, and we are proud […]

Why the Name Change?

We have decided to change the name of our foundation from The Single Cause Single Cure Foundation, to The Foundation for Metabolic Cancer Therapies. We think this name better reflects our ethos. It was pointed out that perhaps Single Cause Single Cure could be interpreted as encouraging patients to seek a single cure. That is not the case. Research has […]

FMCT Supported Research Update: Case Study of Metabolically Supported Chemotherapy

FMCT Supported Research Update: Case Study of Metabolically Supported Chemotherapy

This important publication documents the full remission of a patient with stage 4, triple negative breast cancer. The protocol was designed and refined at Chemothermia Oncology Center in Istanbul Turkey. Dr. Slocum and his colleagues were inspired by the research of Dr. Seyfried and others, and are pioneers in the implementation of metabolic therapies.  

Research Update

Research Update

In May of 2016 we awarded a substantial grant to Dr. Thomas Seyfried’s lab at Boston College. The grant is funding the exploration of a cocktail of metabolic therapies in a metastatic mouse model. The experiment will test the combination of the ketogenic diet, glycolytic inhibitors, oxygen therapy, glutamine inhibitors, exogenous ketones, and other metabolic […]

Research Update

Research Update

The Foundation for Metabolic Cancer Therapies has funded a remarkable study combining oxaloacetate with various metabolic therapies. The results were so compelling that a larger and more comprehensive study was commissioned and is currently underway. We will present the results as soon as we possibly can. On another front, SCSC is in talks to fund a […]